In chronic low back pain, botulinum neurotoxin type A improved patients' pain and functional outcomes vs placebo and other local injection therapies.

HealthDay News — The U.S. Food and Drug Administration has launched the Chemical Contaminants Transparency Tool (CCT Tool), an online searchable database to evaluate potential health risks of ...

Hyperactivation of certain brain regions in children and adolescents with ARFID suggest a new neurobiological circuit associated with the disorder.

Recommendations are presented for the pharmacologic treatment of acute episodic migraine headache in the outpatient setting.

HealthDay News — The total number of births in the United States in 2023 was 3,596,017, which was down 2 percent from 2022, according to the March 18 National Vital Statistics Reports, a publication ...

Recent onset of schizophrenia or other primary psychotic disorders may need intensive support for lives disrupted by their diagnosis.

Loosening restrictions on short-term limited duration (STLD) insurance plans, many of which do not cover essential health benefits such as cancer screening, yields an increase in late-stage cancer ...

For acute low back pain, there is moderate-certainty evidence that nonsteroidal anti-inflammatory drugs are an effective treatment.

The prevalence of chronic conditions (CC) and functional limitations (FL) is increasing among children and young adults.

From 2016 to 2023, there was an increase in the rate of neonatal intensive care unit (NICU) admissions, according to a March data brief published by the National Center for Health Statistics. Joyce A.

Cannabis use is associated with an increased risk for adverse cardiovascular events, including myocardial infarction (MI).

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.